Jaguar Health, Inc. (JAGX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 91.34M |
| Enterprise Value | 121.96M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.75 |
| Price/Book (mrq) | 18.41 |
| Enterprise Value/Revenue | 12.49 |
| Enterprise Value/EBITDA | -3.68 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.38 |
| 52-Week Change 3 | -59.86% |
| S&P500 52-Week Change 3 | 22.38% |
| 52 Week High 3 | 1.2200 |
| 52 Week Low 3 | 0.0510 |
| 50-Day Moving Average 3 | 0.1094 |
| 200-Day Moving Average 3 | 0.2511 |
Share Statistics
| Avg Vol (3 month) 3 | 67.74M |
| Avg Vol (10 day) 3 | 66.72M |
| Shares Outstanding 5 | 287.22M |
| Implied Shares Outstanding 6 | 287.22M |
| Float 8 | 274.29M |
| % Held by Insiders 1 | 7.84% |
| % Held by Institutions 1 | 0.74% |
| Shares Short (Apr 15, 2024) 4 | 14.36M |
| Short Ratio (Apr 15, 2024) 4 | 0.25 |
| Short % of Float (Apr 15, 2024) 4 | 5.00% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 5.00% |
| Shares Short (prior month Mar 15, 2024) 4 | 7.44M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jun 07, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:75 |
| Last Split Date 3 | Jan 23, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -312.44% |
Management Effectiveness
| Return on Assets (ttm) | -43.17% |
| Return on Equity (ttm) | -2,366.62% |
Income Statement
| Revenue (ttm) | 9.76M |
| Revenue Per Share (ttm) | 0.42 |
| Quarterly Revenue Growth (yoy) | -29.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -31.91M |
| Net Income Avi to Common (ttm) | -41.3M |
| Diluted EPS (ttm) | -1.7900 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.47M |
| Total Cash Per Share (mrq) | 0.02 |
| Total Debt (mrq) | 37.09M |
| Total Debt/Equity (mrq) | 757.48% |
| Current Ratio (mrq) | 2.00 |
| Book Value Per Share (mrq) | 0.07 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33.24M |
| Levered Free Cash Flow (ttm) | -17.15M |
© 2024 Yahoo. All rights reserved.